JP2022547197A5 - - Google Patents

Info

Publication number
JP2022547197A5
JP2022547197A5 JP2022515606A JP2022515606A JP2022547197A5 JP 2022547197 A5 JP2022547197 A5 JP 2022547197A5 JP 2022515606 A JP2022515606 A JP 2022515606A JP 2022515606 A JP2022515606 A JP 2022515606A JP 2022547197 A5 JP2022547197 A5 JP 2022547197A5
Authority
JP
Japan
Prior art keywords
modified
capsid protein
unmodified
raav
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022515606A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547197A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/050027 external-priority patent/WO2021050614A2/en
Publication of JP2022547197A publication Critical patent/JP2022547197A/ja
Publication of JP2022547197A5 publication Critical patent/JP2022547197A5/ja
Pending legal-status Critical Current

Links

JP2022515606A 2019-09-09 2020-09-09 アデノ随伴ウイルス(aav)の生体内分布の変更に向けた、aavとaav受容体(aavr)との間の相互作用を調節するための方法および組成物 Pending JP2022547197A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201962897973P 2019-09-09 2019-09-09
US62/897,973 2019-09-09
US201962934996P 2019-11-13 2019-11-13
US62/934,996 2019-11-13
PCT/US2020/050027 WO2021050614A2 (en) 2019-09-09 2020-09-09 Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav

Publications (2)

Publication Number Publication Date
JP2022547197A JP2022547197A (ja) 2022-11-10
JP2022547197A5 true JP2022547197A5 (cg-RX-API-DMAC7.html) 2023-09-15

Family

ID=72826975

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022515606A Pending JP2022547197A (ja) 2019-09-09 2020-09-09 アデノ随伴ウイルス(aav)の生体内分布の変更に向けた、aavとaav受容体(aavr)との間の相互作用を調節するための方法および組成物

Country Status (10)

Country Link
US (1) US12570998B2 (cg-RX-API-DMAC7.html)
EP (1) EP4028531A2 (cg-RX-API-DMAC7.html)
JP (1) JP2022547197A (cg-RX-API-DMAC7.html)
KR (1) KR20220054435A (cg-RX-API-DMAC7.html)
CN (1) CN114667349A (cg-RX-API-DMAC7.html)
AU (1) AU2020347165A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022004183A2 (cg-RX-API-DMAC7.html)
CA (1) CA3153972A1 (cg-RX-API-DMAC7.html)
IL (1) IL291136A (cg-RX-API-DMAC7.html)
WO (1) WO2021050614A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL278598B2 (en) 2018-05-11 2025-11-01 Massachusetts Eye & Ear Infirmary Altering tissue tropism of adeno-associated viruses
CA3153972A1 (en) 2019-09-09 2021-03-18 Massachusetts Eye And Ear Infirmary Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
WO2022150634A2 (en) * 2021-01-08 2022-07-14 Massachusetts Eye And Ear Infirmary Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
US20240352077A1 (en) * 2021-08-25 2024-10-24 Children's Medical Research Institute Modified aav capsids and vectors
WO2023023781A1 (en) * 2021-08-25 2023-03-02 Children's Medical Research Institute Modified aav capsid polypeptides and vectors
KR20240095539A (ko) 2021-10-08 2024-06-25 디노 테라퓨틱스, 인코포레이티드 캡시드 변이체 및 이의 사용 방법
US20250001013A1 (en) * 2021-11-24 2025-01-02 Novartis Ag Modulators of adeno-associated virus transduction and uses thereof
US20250099619A1 (en) * 2021-12-06 2025-03-27 Juntendo Educational Foundation Modified adeno-associated virus vector
AU2024271851A1 (en) 2023-05-16 2025-12-18 Affinia Therapeutics Inc. Recombinant aavs with improved tropism and specificity
WO2025179124A1 (en) * 2024-02-23 2025-08-28 The Board Of Regents Of The University Of Texas System Enhanced aav9 capsid protein
TW202548023A (zh) 2024-03-14 2025-12-16 美商雅菲納治療公司 用於生產重組腺相關病毒的質體系統
WO2025235491A1 (en) 2024-05-07 2025-11-13 Affinia Therapeutics Inc. Recombinant aav for treatment of cardiac diseases

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1668143B1 (en) 2003-09-30 2013-03-20 The Trustees of The University of Pennsylvania Adeno-associated virus (aav) clades, sequences, vectors containing same, and uses therefor
EP1828390B1 (en) 2004-12-15 2012-06-13 The University Of North Carolina At Chapel Hill Chimeric vectors
EP2396343B1 (en) 2009-02-11 2017-05-17 The University of North Carolina At Chapel Hill Modified virus vectors and methods of making and using the same
DK3693025T3 (da) 2011-04-22 2022-01-10 Univ California Adenoassocierede virus-virioner med variant capsid og fremgangsmåder til anvendelse heraf
JP5915467B2 (ja) 2012-08-30 2016-05-11 株式会社島津製作所 液体クロマトグラフ検出器用送液管及び液体クロマトグラフ
ES2926774T3 (es) 2013-03-15 2022-10-28 Univ North Carolina Chapel Hill Métodos y composiciones para vectores AAV de doble unión de glicano
US11136557B2 (en) 2013-05-31 2021-10-05 The Regents Of The University Of California Adeno-associated virus variants and methods of use thereof
EP3049527A4 (en) 2013-09-26 2017-08-16 University of Florida Research Foundation, Inc. Synthetic combinatorial aav capsid library for targeted gene therapy
HUE052676T2 (hu) 2013-10-11 2021-05-28 Massachusetts Eye & Ear Infirmary Eljárások õsi vírusszekvenciák elõrejelzésére és alkalmazásaik
US9474181B2 (en) 2013-12-23 2016-10-18 Dell Products, L.P. Combined power and management module for use in a rack-configured information handling system
US10746742B2 (en) 2014-04-25 2020-08-18 Oregon Health & Science University Methods of viral neutralizing antibody epitope mapping
JP6475998B2 (ja) 2015-02-10 2019-02-27 デクセリアルズ株式会社 タッチパッド用アンテナ装置、及び電子機器
EP4134375A1 (en) 2015-07-30 2023-02-15 Massachusetts Eye & Ear Infirmary Ancestral adeno associated virus sequences and uses thereof
WO2017096164A1 (en) 2015-12-02 2017-06-08 The Board Of Trustees Of The Leland Stanford Junior University Novel recombinant adeno-associated virus capsids with enhanced human skeletal muscle tropism
CA3007476A1 (en) 2015-12-11 2017-06-15 Massachusetts Eye And Ear Infirmary Materials and methods for delivering nucleic acids to cochlear and vestibular cells
CA3014637A1 (en) 2016-02-16 2017-08-24 Mark A. Kay Novel recombinant adeno-associated virus capsids resistant to pre-existing human neutralizing antibodies
JP6936788B2 (ja) 2016-04-01 2021-09-22 株式会社カネカ 軽量化及びリブ設計が可能な樹脂組成物による表面性が良好な射出発泡成形体
JP6994018B2 (ja) 2016-07-26 2022-01-14 バイオマリン ファーマシューティカル インコーポレイテッド 新規アデノ随伴ウイルスキャプシドタンパク質
KR20190075964A (ko) 2016-10-13 2019-07-01 유니버시티 오브 매사추세츠 Aav 캡시드 설계
EP3583220A4 (en) * 2017-02-15 2021-07-07 The University of North Carolina at Chapel Hill PROCEDURES AND COMPOSITIONS FOR GENERAL TRANSFER IN THE VASCULAR SYSTEM
WO2018209154A1 (en) 2017-05-10 2018-11-15 Massachusetts Eye And Ear Infirmary Methods and compositions for modifying assembly-activating protein (app)-dependence of viruses
US11512327B2 (en) * 2017-08-03 2022-11-29 Voyager Therapeutics, Inc. Compositions and methods for delivery of AAV
US11247659B2 (en) 2017-08-08 2022-02-15 Aisin Seiki Kabushiki Kaisha Vehicle control apparatus
US11766489B2 (en) * 2017-11-27 2023-09-26 4D Molecular Therapeutics, Inc. Adeno-associated virus variant capsids and use for inhibiting angiogenesis
IL278598B2 (en) 2018-05-11 2025-11-01 Massachusetts Eye & Ear Infirmary Altering tissue tropism of adeno-associated viruses
US12195745B2 (en) 2018-08-21 2025-01-14 Massachusetts Eye And Ear Infirmary Compositions and methods for modulating transduction efficiency of adeno-associated viruses
CA3153972A1 (en) 2019-09-09 2021-03-18 Massachusetts Eye And Ear Infirmary Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav
WO2022150634A2 (en) 2021-01-08 2022-07-14 Massachusetts Eye And Ear Infirmary Methods and compositions for modulating the interaction between adeno-associated virus (aav) and the aav receptor (aavr) for altered bio-distribution of aav

Similar Documents

Publication Publication Date Title
JP2019116492A5 (cg-RX-API-DMAC7.html)
JP2024009857A5 (cg-RX-API-DMAC7.html)
IL299325B2 (en) Acid-alpha glucosidase variants and uses thereof
JP2017509632A5 (cg-RX-API-DMAC7.html)
JP2022508182A5 (cg-RX-API-DMAC7.html)
JP2022529631A5 (cg-RX-API-DMAC7.html)
IL273261B2 (en) Adeno-associated virus variant capsids and methods of using them
JP2020522269A5 (cg-RX-API-DMAC7.html)
JP2022523679A5 (cg-RX-API-DMAC7.html)
JP2023514242A5 (cg-RX-API-DMAC7.html)
JP2023537625A5 (cg-RX-API-DMAC7.html)
JP2019503649A5 (cg-RX-API-DMAC7.html)
JP2022060228A5 (cg-RX-API-DMAC7.html)
JP2007507223A5 (cg-RX-API-DMAC7.html)
JP2021523718A5 (cg-RX-API-DMAC7.html)
JP2025515979A5 (cg-RX-API-DMAC7.html)
WO2023060269A4 (en) Recombinant adeno-associated viruses for targeted delivery
JP2020519284A5 (cg-RX-API-DMAC7.html)
JP2017529395A5 (cg-RX-API-DMAC7.html)
JP2022551744A5 (cg-RX-API-DMAC7.html)
JP2023535620A5 (cg-RX-API-DMAC7.html)
JP2022525302A5 (cg-RX-API-DMAC7.html)
JP2023537358A5 (cg-RX-API-DMAC7.html)
JP2021520811A5 (cg-RX-API-DMAC7.html)
JP2023550581A5 (cg-RX-API-DMAC7.html)